Department of Health Science, Digestive Surgery Unit, Medical School, University "Magna Graecia", Viale Europa, Germaneto, 88100 Catanzaro, Italy.
Interventional Oncology Unit with Integrated Section of Translational Medical Oncology, National Cancer Research Centre, Istituto Tumori "Giovanni Paolo II", Viale Orazio Flacco 65, 70124 Bari, Italy.
Cells. 2021 Feb 19;10(2):444. doi: 10.3390/cells10020444.
Mast cells (MCs) contain proangiogenic factors, in particular tryptase, associated with increased angiogenesis in several tumours. With special reference to pancreatic cancer, few data have been published on the role of MCs in angiogenesis in both pancreatic ductal adenocarcinoma tissue (PDAT) and adjacent normal tissue (ANT). In this study, density of mast cells positive for c-Kit receptor (MCDP-c-KitR), density of mast cells positive for tryptase (MCDPT), area of mast cells positive for tryptase (MCAPT), and angiogenesis in terms of microvascular density (MVD) and endothelial area (EA) were evaluated in a total of 45 PDAT patients with stage TNM.
For each analysed tissue parameter, the mean ± standard deviation was evaluated in both PDAT and ANT and differences were evaluated by Student's -test ( ranged from 0.001 to 0.005). Each analysed tissue parameter was then correlated to each other one by Pearson -test analysis ( ranged from 0.01 to 0.03). No other correlation among MCDP-c-KitR, MCDPT, MCAPT, MVD, EA and the main clinical-pathological characteristics was found.
Our results suggest that tissue parameters increased from ANT to PDAT and that mast cells are strongly associated with angiogenesis in PDAT. On this basis, the inhibition of MCs through tyrosine kinase inhibitors, such as masitinib, or inhibition of tryptase by gabexate mesylate may become potential novel antiangiogenetic approaches in pancreatic cancer therapy.
肥大细胞(MCs)含有与几种肿瘤中血管生成增加相关的促血管生成因子,特别是类胰蛋白酶。关于胰腺癌,很少有数据报道 MCs 在胰腺导管腺癌组织(PDAT)和相邻正常组织(ANT)中的血管生成中的作用。在这项研究中,共评估了 45 例 TNM 分期的 PDAT 患者的 c-Kit 受体阳性肥大细胞密度(MCDP-c-KitR)、类胰蛋白酶阳性肥大细胞密度(MCDPT)、类胰蛋白酶阳性肥大细胞面积(MCAPT)以及微血管密度(MVD)和内皮面积(EA)的血管生成。
对于每个分析的组织参数,在 PDAT 和 ANT 中评估了平均值±标准差,并通过 Student's -test 评估了差异(范围从 0.001 到 0.005)。然后通过 Pearson -test 分析评估了每个分析的组织参数之间的相关性(范围从 0.01 到 0.03)。未发现 MCDP-c-KitR、MCDPT、MCAPT、MVD、EA 与主要临床病理特征之间的其他相关性。
我们的结果表明,组织参数从 ANT 增加到 PDAT,并且肥大细胞与 PDAT 中的血管生成密切相关。在此基础上,通过酪氨酸激酶抑制剂(如马替尼)抑制 MCs 或通过甲磺酸加贝酯抑制类胰蛋白酶可能成为胰腺癌治疗中潜在的新型抗血管生成方法。